Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2010 1
2011 1
2012 1
2013 1
2014 6
2015 1
2016 2
2017 1
2018 5
2019 8
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

30 results
Results by year
Filters applied: . Clear all
Page 1
Mercury Contamination from Dental Amalgam.
Tibau AV, Grube BD. Tibau AV, et al. J Health Pollut. 2019 Jun 4;9(22):190612. doi: 10.5696/2156-9614-9.22.190612. eCollection 2019 Jun. J Health Pollut. 2019. PMID: 31259088 Free PMC article. Review.
Response.
Tibau A, Molto C, Amir E. Tibau A, et al. J Natl Cancer Inst. 2018 Oct 1;110(10):1145. doi: 10.1093/jnci/djy031. J Natl Cancer Inst. 2018. PMID: 29529214 No abstract available.
Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration Based on Single-Arm Trials.
Tibau A, Molto C, Borrell M, Del Paggio JC, Barnadas A, Booth CM, Amir E. Tibau A, et al. JAMA Oncol. 2018 Nov 1;4(11):1610-1611. doi: 10.1001/jamaoncol.2018.4300. JAMA Oncol. 2018. PMID: 30267037 Free PMC article.
Association Between Data Sources and US Food and Drug Administration Drug Safety Communications.
Tau N, Shochat T, Gafter-Gvili A, Tibau A, Amir E, Shepshelovich D. Tau N, et al. Among authors: tibau a. JAMA Intern Med. 2019 Sep 3;179(11):1-3. doi: 10.1001/jamainternmed.2019.3066. Online ahead of print. JAMA Intern Med. 2019. PMID: 31479104 Free PMC article.
Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression.
Templeton AJ, Gonzalez LD, Vera-Badillo FE, Tibau A, Goldstein R, Šeruga B, Srikanthan A, Pandiella A, Amir E, Ocana A. Templeton AJ, et al. Among authors: tibau a. PLoS One. 2016 May 5;11(5):e0154789. doi: 10.1371/journal.pone.0154789. eCollection 2016. PLoS One. 2016. PMID: 27149669 Free PMC article. Review.
Impact of Availability of Companion Diagnostics on the Clinical Development of Anticancer Drugs.
Tibau A, Díez-González L, Navarro B, Galán-Moya EM, Templeton AJ, Seruga B, Pandiella A, Amir E, Ocana A. Tibau A, et al. Mol Diagn Ther. 2017 Jun;21(3):337-343. doi: 10.1007/s40291-017-0267-y. Mol Diagn Ther. 2017. PMID: 28247182
Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration.
Tibau A, Molto C, Ocana A, Templeton AJ, Del Carpio LP, Del Paggio JC, Barnadas A, Booth CM, Amir E. Tibau A, et al. J Natl Cancer Inst. 2018 May 1;110(5):486-492. doi: 10.1093/jnci/djx232. J Natl Cancer Inst. 2018. PMID: 29244173
Safety-Related Postmarketing Modifications of Drugs for Hematological Malignancies.
Gafter-Gvili A, Tibau A, Raanani P, Shepshelovich D. Gafter-Gvili A, et al. Among authors: tibau a. Acta Haematol. 2020;143(1):73-77. doi: 10.1159/000500229. Epub 2019 Jun 5. Acta Haematol. 2020. PMID: 31167178
Patient-Centered Cancer Drug Development: Clinical Trials, Regulatory Approval, and Value Assessment.
Gyawali B, Hwang TJ, Vokinger KN, Booth CM, Amir E, Tibau A. Gyawali B, et al. Among authors: tibau a. Am Soc Clin Oncol Educ Book. 2019 Jan;39:374-387. doi: 10.1200/EDBK_242229. Epub 2019 May 17. Am Soc Clin Oncol Educ Book. 2019. PMID: 31099613 Free article.
Undisclosed financial conflicts of interest among authors of American Society of Clinical Oncology clinical practice guidelines.
Saleh RR, Majeed H, Tibau A, Booth CM, Amir E. Saleh RR, et al. Among authors: tibau a. Cancer. 2019 Nov 15;125(22):4069-4075. doi: 10.1002/cncr.32408. Epub 2019 Jul 29. Cancer. 2019. PMID: 31355923
30 results
Jump to page
Feedback